Assessing and Addressing Quality of Life and Patient-Reported Outcomes: Creating Shared Decision-Making for Hepatitis B Management and Treatment
Nov
10
2025
Convention Center: Room 201, Level 2
9:45 AM - 10:45 AM
World Class Speakers
Description
Panelists highlight the perspectives of providers and people living with hepatitis B regarding strategies to assess and address patient-reported outcomes, and cultivate shared decision-making that is informed by scientific evidence, provider expertise, and patient preferences. The diverse panel includes representatives of nonprofit organizations, health systems, academic institutions, and patient advocacy groups. A question-and-answer period follows speaker presentations.Journey Maps
Presentations
9:45 AM - 9:55 AM
Nov
10
2025
San Diego, CA
The Impacts of Stigma and Discrimination on People Living With Hepatitis B
Ravshan Yakubov, MBA, CPA, CA, Presenter
Hepatitis
9:55 AM - 10:05 AM
Nov
10
2025
San Diego, CA
Role of Treatment on Patient-Reported Outcomes in Hepatitis B
Zobair M Younossi, MD, MPH, FAASLD, Presenter
Hepatitis
10:05 AM - 10:15 AM
Nov
10
2025
San Diego, CA
Strategies for Shared Decision-Making in Hepatitis B Management and Treatment
Su H Wang, MD, MPH, FACP, Presenter
Hepatitis
10:15 AM - 10:25 AM
Nov
10
2025
San Diego, CA
Costs to Patients and Family Related to Hepatitis B Management and Treatment
Wendy Lo, Presenter
Hepatitis
10:25 AM - 10:35 AM
Nov
10
2025
San Diego, CA
Measuring the Quality of Life Impact of Hepatitis B
Donna M. Evon, PhD, Presenter
Hepatitis
Objectives
- Relate the perspectives of people living with hepatitis B regarding treatment eligibility and options, quality of life and important patient-reported outcomes, treatment adherence, and the impacts of stigma and discrimination.
- Identify strategies for assessing hepatitis B quality of life impact in the clinical setting.
- Discuss strategies for using shared decision-making models to enhance provider-patient communication and make hepatitis B management and treatment decisions.